We are live on ! Find out more
AZNH

AstraZeneca
AZNH

Delisted

AZNH was delisted on the 29th of January, 2026.

Back to rankings

1 hedge funds and large institutions have $3.63M invested in AstraZeneca in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

135% more capital invested

Capital invested by funds: $1.55M → $3.63M (+$2.09M)

21.45% more ownership

Funds ownership: 91.87% → 113.32% (+21%)

50% less funds holding

Funds holding: 2 → 1 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$1.96M

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$4.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$3.63M +$1.96M +42,682 +116%
UBS Group
2
UBS Group
Switzerland
– -$4.5K -107 Closed

AZNH Hedge Fund Activity: Q1 2025 in Review

1 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZNH) for Q1 2025, worth a combined $3.63M — up 135% from $1.55M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of AZNH and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was Citadel Advisors, adding an estimated $1.96M. The largest seller was UBS Group, exiting entirely with an estimated $4.5K sold.

  • 1 institutional investor held AstraZeneca (AZNH) as of Q1 2025, down from 2 in Q4 2024.
  • Funds reported $3.63M of AstraZeneca stock for Q1 2025, up 135% quarter-over-quarter.
  • 0 funds opened new AstraZeneca positions in Q1 2025 and 1 closed out, a net change of -1 holder.
  • The largest AstraZeneca buyer in Q1 2025 was Citadel Advisors, an estimated $1.96M added.
  • The largest AstraZeneca seller in Q1 2025 was UBS Group, an estimated $4.5K sold.

Based on aggregated 13F filings for Q1 2025.